180 Life Sciences Corp (ATNF)
1.97
-0.02
(-1.01%)
USD |
NASDAQ |
May 02, 16:00
1.97
0.00 (0.00%)
After-Hours: 20:00
180 Life Sciences 1 Year Total Returns (Daily): -90.48% for May 1, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 01, 2024 | -90.48% |
April 30, 2024 | -90.16% |
April 29, 2024 | -91.03% |
April 26, 2024 | -91.15% |
April 25, 2024 | -91.54% |
April 24, 2024 | -91.74% |
April 23, 2024 | -91.60% |
April 22, 2024 | -92.04% |
April 19, 2024 | -92.15% |
April 18, 2024 | -92.53% |
April 17, 2024 | -92.21% |
April 16, 2024 | -93.72% |
April 15, 2024 | -91.36% |
April 12, 2024 | -90.68% |
April 11, 2024 | -90.50% |
April 10, 2024 | -89.30% |
April 09, 2024 | -90.07% |
April 08, 2024 | -90.09% |
April 05, 2024 | -91.79% |
April 04, 2024 | -93.52% |
April 03, 2024 | -93.71% |
April 02, 2024 | -93.86% |
April 01, 2024 | -93.57% |
March 28, 2024 | -93.34% |
March 27, 2024 | -94.34% |
Date | Value |
---|---|
March 26, 2024 | -94.71% |
March 25, 2024 | -94.30% |
March 22, 2024 | -92.71% |
March 21, 2024 | -91.07% |
March 20, 2024 | -91.38% |
March 19, 2024 | -92.01% |
March 18, 2024 | -91.61% |
March 15, 2024 | -91.10% |
March 14, 2024 | -91.84% |
March 13, 2024 | -92.28% |
March 12, 2024 | -91.67% |
March 11, 2024 | -91.96% |
March 08, 2024 | -93.24% |
March 07, 2024 | -92.23% |
March 06, 2024 | -93.00% |
March 05, 2024 | -92.81% |
March 04, 2024 | -93.65% |
March 01, 2024 | -93.82% |
February 29, 2024 | -93.54% |
February 28, 2024 | -94.22% |
February 27, 2024 | -93.21% |
February 26, 2024 | -92.65% |
February 23, 2024 | -93.03% |
February 22, 2024 | -93.60% |
February 21, 2024 | -93.64% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-98.51%
Minimum
Dec 23 2022
132.8%
Maximum
Nov 30 2021
-46.50%
Average
-52.78%
Median
1 Year Total Returns (Daily) Benchmarks
Seelos Therapeutics Inc | -98.55% |
Altimmune Inc | 43.70% |
GT Biopharma Inc | -71.44% |
Outlook Therapeutics Inc | -63.63% |
MAIA Biotechnology Inc | 10.19% |